Your browser doesn't support javascript.
loading
Impact of a New Fusion Receptor on PD-1-Mediated Immunosuppression in Adoptive T Cell Therapy.
Kobold, Sebastian; Grassmann, Simon; Chaloupka, Michael; Lampert, Christopher; Wenk, Susanne; Kraus, Fabian; Rapp, Moritz; Düwell, Peter; Zeng, Yi; Schmollinger, Jan C; Schnurr, Max; Endres, Stefan; Rothenfußer, Simon.
Afiliación
  • Kobold S; Center of Integrated Protein Science Munich and Division of Clinical Pharmacology, Department of Internal Medicine IV, Ludwig-Maximilians-Universität München, Munich, Germany, Member of the German Center for Lung Research (SK, SG, MC, CL, SW, FK, MR, PD, YZ, JCS, MS, SE SR).
  • Grassmann S; Center of Integrated Protein Science Munich and Division of Clinical Pharmacology, Department of Internal Medicine IV, Ludwig-Maximilians-Universität München, Munich, Germany, Member of the German Center for Lung Research (SK, SG, MC, CL, SW, FK, MR, PD, YZ, JCS, MS, SE SR).
  • Chaloupka M; Center of Integrated Protein Science Munich and Division of Clinical Pharmacology, Department of Internal Medicine IV, Ludwig-Maximilians-Universität München, Munich, Germany, Member of the German Center for Lung Research (SK, SG, MC, CL, SW, FK, MR, PD, YZ, JCS, MS, SE SR).
  • Lampert C; Center of Integrated Protein Science Munich and Division of Clinical Pharmacology, Department of Internal Medicine IV, Ludwig-Maximilians-Universität München, Munich, Germany, Member of the German Center for Lung Research (SK, SG, MC, CL, SW, FK, MR, PD, YZ, JCS, MS, SE SR).
  • Wenk S; Center of Integrated Protein Science Munich and Division of Clinical Pharmacology, Department of Internal Medicine IV, Ludwig-Maximilians-Universität München, Munich, Germany, Member of the German Center for Lung Research (SK, SG, MC, CL, SW, FK, MR, PD, YZ, JCS, MS, SE SR).
  • Kraus F; Center of Integrated Protein Science Munich and Division of Clinical Pharmacology, Department of Internal Medicine IV, Ludwig-Maximilians-Universität München, Munich, Germany, Member of the German Center for Lung Research (SK, SG, MC, CL, SW, FK, MR, PD, YZ, JCS, MS, SE SR).
  • Rapp M; Center of Integrated Protein Science Munich and Division of Clinical Pharmacology, Department of Internal Medicine IV, Ludwig-Maximilians-Universität München, Munich, Germany, Member of the German Center for Lung Research (SK, SG, MC, CL, SW, FK, MR, PD, YZ, JCS, MS, SE SR).
  • Düwell P; Center of Integrated Protein Science Munich and Division of Clinical Pharmacology, Department of Internal Medicine IV, Ludwig-Maximilians-Universität München, Munich, Germany, Member of the German Center for Lung Research (SK, SG, MC, CL, SW, FK, MR, PD, YZ, JCS, MS, SE SR).
  • Zeng Y; Center of Integrated Protein Science Munich and Division of Clinical Pharmacology, Department of Internal Medicine IV, Ludwig-Maximilians-Universität München, Munich, Germany, Member of the German Center for Lung Research (SK, SG, MC, CL, SW, FK, MR, PD, YZ, JCS, MS, SE SR).
  • Schmollinger JC; Center of Integrated Protein Science Munich and Division of Clinical Pharmacology, Department of Internal Medicine IV, Ludwig-Maximilians-Universität München, Munich, Germany, Member of the German Center for Lung Research (SK, SG, MC, CL, SW, FK, MR, PD, YZ, JCS, MS, SE SR).
  • Schnurr M; Center of Integrated Protein Science Munich and Division of Clinical Pharmacology, Department of Internal Medicine IV, Ludwig-Maximilians-Universität München, Munich, Germany, Member of the German Center for Lung Research (SK, SG, MC, CL, SW, FK, MR, PD, YZ, JCS, MS, SE SR).
  • Endres S; Center of Integrated Protein Science Munich and Division of Clinical Pharmacology, Department of Internal Medicine IV, Ludwig-Maximilians-Universität München, Munich, Germany, Member of the German Center for Lung Research (SK, SG, MC, CL, SW, FK, MR, PD, YZ, JCS, MS, SE SR).
  • Rothenfußer S; Center of Integrated Protein Science Munich and Division of Clinical Pharmacology, Department of Internal Medicine IV, Ludwig-Maximilians-Universität München, Munich, Germany, Member of the German Center for Lung Research (SK, SG, MC, CL, SW, FK, MR, PD, YZ, JCS, MS, SE SR).
J Natl Cancer Inst ; 107(8)2015 Aug.
Article en En | MEDLINE | ID: mdl-26105028
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Ovalbúmina / Terapia de Inmunosupresión / Interferón gamma / Antígenos CD28 / Linfocitos T CD8-positivos / Traslado Adoptivo / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 Límite: Animals Idioma: En Revista: J Natl Cancer Inst Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Ovalbúmina / Terapia de Inmunosupresión / Interferón gamma / Antígenos CD28 / Linfocitos T CD8-positivos / Traslado Adoptivo / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 Límite: Animals Idioma: En Revista: J Natl Cancer Inst Año: 2015 Tipo del documento: Article